CLINICAL_TRIALS ClinicalTrials.gov record update

Adaptive Stereotactic Radiotherapy With Superparamagnetic Iron Oxide Nanoparticles (SPION) Cellular Magnetic Resonance Imaging on MR-Linac (MR-L-SPION) for Primary and Metastatic Hepatic Malignancies With Assessment of Treatment Response.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04682847
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:40:00.071652+00:00
Published At: 2024-01-31T00:00:00+00:00
Record Updated At: 2024-01-31
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Liver Neoplasms", "Hepatic Cirrhosis", "Hepatic Carcinoma", "Liver Cancer", "Liver Metastases", "Liver Carcinoma", "Hepatocellular Carcinoma", "Hepatocellular Cancer", "Hepatic Atrophy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-01-31"
protocolSection.identificationModule.nctId: "NCT04682847"
protocolSection.identificationModule.officialTitle: "Adaptive Stereotactic Radiotherapy With Superparamagnetic Iron Oxide Nanoparticles (SPION) Cellular Magnetic Resonance Imaging on MR-Linac (MR-L-SPION) for Primary and Metastatic Hepatic Malignancies With Assessment of Treatment Response."
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.